Market Tracker

04/24 6:05pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
4.83 -0.09 / -1.83%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.83 0.00 / 0.00%
 
Volume: 6.2K

Today’s Trading

Previous close4.92
Today’s open4.93
Day’s range4.71 - 5.19
Volume663,075
Average volume (3 months)1,381,326
Market cap$466.7M
Dividend yield--
Data as of 3:59pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+11.99%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ITCIITI Inc+0.06+0.37%
ACRXAcelRx Pharmaceutica...+0.15+1.38%
VNDAVanda Pharmaceutical...-0.79-5.41%
ARRYArray Biopharma Inc+0.29+7.63%
Data as of 4:00pm ET, 04/24/2014

Financials

Next reporting dateMay 13, 2014
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts